Advanced Biomed Inc Comprehensive Income
Advanced Biomed Inc (ADVB) reported Comprehensive Income of -$519.90 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-05-15
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$519.90K.
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $6.48M.
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$473.44K.
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$652.22K.
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$3.04M.
- Advanced Biomed Inc comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$2.46M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$519.90K 10-Q · filed 2026-05-15 | $5.96M derived: sum of 2 quarters · filed 2026-05-15 | $5.48M 10-Q · filed 2026-05-15 | $4.83M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $6.48M 10-Q · filed 2026-02-13 | $6.00M 10-Q · filed 2026-02-13 | $5.35M derived: sum of 3 quarters · filed 2026-02-13 | $4.01M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | -$473.44K 10-Q · filed 2025-11-19 | -$1.13M derived: sum of 2 quarters · filed 2025-11-19 | -$2.47M derived: sum of 3 quarters · filed 2026-05-15 | -$2.94M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$652.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$2.00M derived: sum of 2 quarters · filed 2026-05-15 | -$2.47M derived: sum of 3 quarters · filed 2026-05-15 | -$3.04M 10-K · filed 2025-10-08 |
| 2025-03-31 | -$1.34M 10-Q · filed 2026-05-15 | -$1.82M derived: sum of 2 quarters · filed 2026-05-15 | -$2.39M 10-Q · filed 2026-05-15 | -$3.05M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$474.80K 10-Q · filed 2026-02-13 | -$1.04M 10-Q · filed 2026-02-13 | -$1.70M derived: sum of 3 quarters · filed 2026-02-13 | -$2.40M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$569.43K 10-Q · filed 2025-11-19 | -$1.23M derived: sum of 2 quarters · filed 2025-11-19 | -$1.92M derived: sum of 3 quarters · filed 2025-11-19 | -$2.53M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | -$659.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$1.35M derived: sum of 2 quarters · filed 2025-10-08 | -$1.96M derived: sum of 3 quarters · filed 2025-10-08 | -$2.46M 10-K · filed 2025-10-08 |
| 2024-03-31 | -$694.64K 10-Q · filed 2025-05-15 | -$1.30M derived: sum of 2 quarters · filed 2025-05-15 | -$1.80M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | -$608.30K 10-Q · filed 2025-04-15 | -$1.11M 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |